Skip to main content
Fig. 2 | World Journal of Surgical Oncology

Fig. 2

From: Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer

Fig. 2

Disease-specific survival curves according to NSCLC cells expression of KAI1. a In the total cohort of patients (n = 312), the median survival in the negative expression of KAI1 group was 34.6 months, compared with 67.3 months in the positive expression of KAI1 group. b In all patients with N+ status (n = 159), the median survival in the negative expression of KAI1 group was 32.0 months, compared with 79.2 months in the positive expression of KAI1 group

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us